95TH GENERAL ASSEMBLY
State of Illinois
2007 and 2008
SB0226

 

Introduced 2/7/2007, by Sen. John J. Millner

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/204   from Ch. 56 1/2, par. 1204

    Amends the Illinois Controlled Substances Act. Provides that Salvia divinorum is a Schedule I controlled substance.


LRB095 08254 RLC 28426 b

CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY

 

 

A BILL FOR

 

SB0226 LRB095 08254 RLC 28426 b

1     AN ACT concerning criminal law.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 5. The Illinois Controlled Substances Act is
5 amended by changing Section 204 as follows:
 
6     (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
7     Sec. 204. (a) The controlled substances listed in this
8 Section are included in Schedule I.
9     (b) Unless specifically excepted or unless listed in
10 another schedule, any of the following opiates, including their
11 isomers, esters, ethers, salts, and salts of isomers, esters,
12 and ethers, whenever the existence of such isomers, esters,
13 ethers and salts is possible within the specific chemical
14 designation:
15         (1) Acetylmethadol;
16         (1.1) Acetyl-alpha-methylfentanyl
17     (N-[1-(1-methyl-2-phenethyl)-
18     4-piperidinyl]-N-phenylacetamide);
19         (2) Allylprodine;
20         (3) Alphacetylmethadol, except
21     levo-alphacetylmethadol (also known as levo-alpha-
22     acetylmethadol, levomethadyl acetate, or LAAM);
23         (4) Alphameprodine;

 

 

SB0226 - 2 - LRB095 08254 RLC 28426 b

1         (5) Alphamethadol;
2         (6) Alpha-methylfentanyl
3     (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
4     propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
5     propanilido) piperidine;
6         (6.1) Alpha-methylthiofentanyl
7     (N-[1-methyl-2-(2-thienyl)ethyl-
8     4-piperidinyl]-N-phenylpropanamide);
9         (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
10         (7) 1-methyl-4-phenyl-4-proprionoxypiperidine (MPPP);
11         (7.1) PEPAP
12     (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
13         (8) Benzethidine;
14         (9) Betacetylmethadol;
15         (9.1) Beta-hydroxyfentanyl
16     (N-[1-(2-hydroxy-2-phenethyl)-
17     4-piperidinyl]-N-phenylpropanamide);
18         (10) Betameprodine;
19         (11) Betamethadol;
20         (12) Betaprodine;
21         (13) Clonitazene;
22         (14) Dextromoramide;
23         (15) Diampromide;
24         (16) Diethylthiambutene;
25         (17) Difenoxin;
26         (18) Dimenoxadol;

 

 

SB0226 - 3 - LRB095 08254 RLC 28426 b

1         (19) Dimepheptanol;
2         (20) Dimethylthiambutene;
3         (21) Dioxaphetylbutyrate;
4         (22) Dipipanone;
5         (23) Ethylmethylthiambutene;
6         (24) Etonitazene;
7         (25) Etoxeridine;
8         (26) Furethidine;
9         (27) Hydroxpethidine;
10         (28) Ketobemidone;
11         (29) Levomoramide;
12         (30) Levophenacylmorphan;
13         (31) 3-Methylfentanyl
14     (N-[3-methyl-1-(2-phenylethyl)-
15     4-piperidyl]-N-phenylpropanamide);
16         (31.1) 3-Methylthiofentanyl
17     (N-[(3-methyl-1-(2-thienyl)ethyl-
18     4-piperidinyl]-N-phenylpropanamide);
19         (32) Morpheridine;
20         (33) Noracymethadol;
21         (34) Norlevorphanol;
22         (35) Normethadone;
23         (36) Norpipanone;
24         (36.1) Para-fluorofentanyl
25     (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
26     4-piperidinyl]propanamide);

 

 

SB0226 - 4 - LRB095 08254 RLC 28426 b

1         (37) Phenadoxone;
2         (38) Phenampromide;
3         (39) Phenomorphan;
4         (40) Phenoperidine;
5         (41) Piritramide;
6         (42) Proheptazine;
7         (43) Properidine;
8         (44) Propiram;
9         (45) Racemoramide;
10         (45.1) Thiofentanyl
11     (N-phenyl-N-[1-(2-thienyl)ethyl-
12     4-piperidinyl]-propanamide);
13         (46) Tilidine;
14         (47) Trimeperidine;
15         (48) Beta-hydroxy-3-methylfentanyl (other name:
16     N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
17     N-phenylpropanamide).
18     (c) Unless specifically excepted or unless listed in
19 another schedule, any of the following opium derivatives, its
20 salts, isomers and salts of isomers, whenever the existence of
21 such salts, isomers and salts of isomers is possible within the
22 specific chemical designation:
23         (1) Acetorphine;
24         (2) Acetyldihydrocodeine;
25         (3) Benzylmorphine;
26         (4) Codeine methylbromide;

 

 

SB0226 - 5 - LRB095 08254 RLC 28426 b

1         (5) Codeine-N-Oxide;
2         (6) Cyprenorphine;
3         (7) Desomorphine;
4         (8) Diacetyldihydromorphine (Dihydroheroin);
5         (9) Dihydromorphine;
6         (10) Drotebanol;
7         (11) Etorphine (except hydrochloride salt);
8         (12) Heroin;
9         (13) Hydromorphinol;
10         (14) Methyldesorphine;
11         (15) Methyldihydromorphine;
12         (16) Morphine methylbromide;
13         (17) Morphine methylsulfonate;
14         (18) Morphine-N-Oxide;
15         (19) Myrophine;
16         (20) Nicocodeine;
17         (21) Nicomorphine;
18         (22) Normorphine;
19         (23) Pholcodine;
20         (24) Thebacon.
21     (d) Unless specifically excepted or unless listed in
22 another schedule, any material, compound, mixture, or
23 preparation which contains any quantity of the following
24 hallucinogenic substances, or which contains any of its salts,
25 isomers and salts of isomers, whenever the existence of such
26 salts, isomers, and salts of isomers is possible within the

 

 

SB0226 - 6 - LRB095 08254 RLC 28426 b

1 specific chemical designation (for the purposes of this
2 paragraph only, the term "isomer" includes the optical,
3 position and geometric isomers):
4         (1) 3,4-methylenedioxyamphetamine
5     (alpha-methyl,3,4-methylenedioxyphenethylamine,
6     methylenedioxyamphetamine, MDA);
7         (1.1) Alpha-ethyltryptamine
8     (some trade or other names: etryptamine;
9     MONASE; alpha-ethyl-1H-indole-3-ethanamine;
10     3-(2-aminobutyl)indole; a-ET; and AET);
11         (2) 3,4-methylenedioxymethamphetamine (MDMA);
12         (2.1) 3,4-methylenedioxy-N-ethylamphetamine
13     (also known as: N-ethyl-alpha-methyl-
14     3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
15     and MDEA);
16         (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
17         (4) 3,4,5-trimethoxyamphetamine (TMA);
18         (5) (Blank);
19         (6) Diethyltryptamine (DET);
20         (7) Dimethyltryptamine (DMT);
21         (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
22         (9) Ibogaine  (some trade and other names:
23     7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
24     6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
25     indole; Tabernanthe iboga);
26         (10) Lysergic acid diethylamide;

 

 

SB0226 - 7 - LRB095 08254 RLC 28426 b

1         (10.5) Salvia divinorum;
2         (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
3         (12) Peyote (meaning all parts of the plant presently
4     classified botanically as Lophophora williamsii williemaii
5     Lemaire, whether growing or not, the seeds thereof, any
6     extract from any part of that plant, and every compound,
7     manufacture, salts, derivative, mixture, or preparation of
8     that plant, its seeds or extracts);
9         (13) N-ethyl-3-piperidyl benzilate (JB 318);
10         (14) N-methyl-3-piperidyl benzilate;
11         (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
12     (also known as N-hydroxy-alpha-methyl-
13     3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
14         (15) Parahexyl; some trade or other names:
15     3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
16     dibenzo (b,d) pyran; Synhexyl;
17         (16) Psilocybin;
18         (17) Psilocyn;
19         (18) Alpha-methyltryptamine (AMT);
20         (19) 2,5-dimethoxyamphetamine
21     (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
22         (20) 4-bromo-2,5-dimethoxyamphetamine
23     (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
24     4-bromo-2,5-DMA);
25         (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
26     Some trade or other names: 2-(4-bromo-

 

 

SB0226 - 8 - LRB095 08254 RLC 28426 b

1     2,5-dimethoxyphenyl)-1-aminoethane;
2     alpha-desmethyl DOB, 2CB, Nexus;
3         (21) 4-methoxyamphetamine
4     (4-methoxy-alpha-methylphenethylamine;
5     paramethoxyamphetamine; PMA);
6         (22) (Blank);
7         (23) Ethylamine analog of phencyclidine.
8     Some trade or other names:
9     N-ethyl-1-phenylcyclohexylamine,
10     (1-phenylcyclohexyl) ethylamine,
11     N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
12         (24) Pyrrolidine analog of phencyclidine. Some trade
13     or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
14     PHP;
15         (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
16         (26) 2,5-dimethoxy-4-ethylamphetamine
17     (another name: DOET);
18         (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
19     (another name: TCPy);
20         (28) (Blank);
21         (29) Thiophene analog of phencyclidine (some trade
22     or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
23     2-thienyl analog of phencyclidine; TPCP; TCP);
24         (30) Bufotenine (some trade or other names:
25     3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
26     3-(2-dimethylaminoethyl)-5-indolol;

 

 

SB0226 - 9 - LRB095 08254 RLC 28426 b

1     5-hydroxy-N,N-dimethyltryptamine;
2     N,N-dimethylserotonin; mappine).
3     (e) Unless specifically excepted or unless listed in
4 another schedule, any material, compound, mixture, or
5 preparation which contains any quantity of the following
6 substances having a depressant effect on the central nervous
7 system, including its salts, isomers, and salts of isomers
8 whenever the existence of such salts, isomers, and salts of
9 isomers is possible within the specific chemical designation:
10         (1) mecloqualone;
11         (2) methaqualone; and
12         (3) gamma hydroxybutyric acid.
13     (f) Unless specifically excepted or unless listed in
14 another schedule, any material, compound, mixture, or
15 preparation which contains any quantity of the following
16 substances having a stimulant effect on the central nervous
17 system, including its salts, isomers, and salts of isomers:
18         (1) Fenethylline;
19         (2) N-ethylamphetamine;
20         (3) Aminorex (some other names:
21     2-amino-5-phenyl-2-oxazoline; aminoxaphen;
22     4-5-dihydro-5-phenyl-2-oxazolamine) and its
23     salts, optical isomers, and salts of optical isomers;
24         (4) Methcathinone (some other names:
25     2-methylamino-1-phenylpropan-1-one;
26     Ephedrone; 2-(methylamino)-propiophenone;

 

 

SB0226 - 10 - LRB095 08254 RLC 28426 b

1     alpha-(methylamino)propiophenone; N-methylcathinone;
2     methycathinone; Monomethylpropion; UR 1431) and its
3     salts, optical isomers, and salts of optical isomers;
4         (5) Cathinone (some trade or other names:
5     2-aminopropiophenone; alpha-aminopropiophenone;
6     2-amino-1-phenyl-propanone; norephedrone);
7         (6) N,N-dimethylamphetamine (also known as:
8     N,N-alpha-trimethyl-benzeneethanamine;
9     N,N-alpha-trimethylphenethylamine);
10         (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
11     4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
12     (g) Temporary listing of substances subject to emergency
13 scheduling. Any material, compound, mixture, or preparation
14 that contains any quantity of the following substances:
15         (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
16     (benzylfentanyl), its optical isomers, isomers, salts,
17     and salts of isomers;
18         (2) N-[1(2-thienyl)
19    methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
20    its optical isomers, salts, and salts of isomers.
21 (Source: P.A. 90-382, eff. 8-15-97; 91-714, eff. 6-2-00;
22 revised 10-18-05.)